These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
710 related articles for article (PubMed ID: 25824424)
1. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial. Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424 [TBL] [Abstract][Full Text] [Related]
2. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression. Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220 [TBL] [Abstract][Full Text] [Related]
3. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial. Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711 [TBL] [Abstract][Full Text] [Related]
4. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report. van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359 [TBL] [Abstract][Full Text] [Related]
5. Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial. Grieve SM; Korgaonkar MS; Etkin A; Harris A; Koslow SH; Wisniewski S; Schatzberg AF; Nemeroff CB; Gordon E; Williams LM Trials; 2013 Jul; 14():224. PubMed ID: 23866851 [TBL] [Abstract][Full Text] [Related]
7. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome? Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227 [TBL] [Abstract][Full Text] [Related]
8. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study. Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202 [TBL] [Abstract][Full Text] [Related]
9. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging. Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427 [TBL] [Abstract][Full Text] [Related]
10. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E Trials; 2011 Jan; 12():4. PubMed ID: 21208417 [TBL] [Abstract][Full Text] [Related]
11. Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Suslow T; Konrad C; Kugel H; Rumstadt D; Zwitserlood P; Schöning S; Ohrmann P; Bauer J; Pyka M; Kersting A; Arolt V; Heindel W; Dannlowski U Biol Psychiatry; 2010 Jan; 67(2):155-60. PubMed ID: 19748075 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399 [TBL] [Abstract][Full Text] [Related]
14. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Victor TA; Furey ML; Fromm SJ; Ohman A; Drevets WC Arch Gen Psychiatry; 2010 Nov; 67(11):1128-38. PubMed ID: 21041614 [TBL] [Abstract][Full Text] [Related]
15. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report. van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703 [TBL] [Abstract][Full Text] [Related]
16. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression. Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798 [TBL] [Abstract][Full Text] [Related]
17. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298 [TBL] [Abstract][Full Text] [Related]
18. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327 [TBL] [Abstract][Full Text] [Related]
19. Amygdala Activation and Connectivity to Emotional Processing Distinguishes Asymptomatic Patients With Bipolar Disorders and Unipolar Depression. Korgaonkar MS; Erlinger M; Breukelaar IA; Boyce P; Hazell P; Antees C; Foster S; Grieve SM; Gomes L; Williams LM; Harris AWF; Malhi GS Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Apr; 4(4):361-370. PubMed ID: 30343134 [TBL] [Abstract][Full Text] [Related]
20. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]